Pharma-Bio Serv, Inc.
PBSV
$0.55
$0.07515.79%
| Weiss Ratings | PBSV - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | C- | |||
| Rating Factors | PBSV - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Good | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | PBSV - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.06 | |||
| Price History | PBSV - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 4.76% | |||
| 30-Day Total Return | 8.19% | |||
| 60-Day Total Return | 25.71% | |||
| 90-Day Total Return | 8.37% | |||
| Year to Date Total Return | 14.31% | |||
| 1-Year Total Return | -30.16% | |||
| 2-Year Total Return | -33.51% | |||
| 3-Year Total Return | -13.72% | |||
| 5-Year Total Return | 5.08% | |||
| 52-Week High % Change | -47.22% | |||
| 52-Week Low % Change | 51.90% | |||
| Price | PBSV - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.90 | |||
| 52-Week Low Price | $0.31 | |||
| 52-Week Low Price (Date) | Nov 20, 2024 | |||
| 52-Week High Price (Date) | Mar 08, 2024 | |||
| Valuation | PBSV - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 10.91M | |||
| Enterprise Value | -1.65M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.03 | |||
| Earnings Per Share Growth | -160.70% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.15 | |||
| Price/Book (Q) | 0.80 | |||
| Enterprise Value/Revenue (TTM) | -0.17 | |||
| Price | $0.55 | |||
| Enterprise Value/EBITDA (TTM) | 1.30 | |||
| Enterprise Value/EBIT | 1.28 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | PBSV - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 22.97M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | $0.08 | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -221.48% | |||
| Dividend Per Share (Most Recent) | $0.08 | |||
| Company Info | PBSV - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 787 278 2709 | |||
| Address | #6 Road 696 Dorado, PR 00646-3306 | |||
| Website | www.pbsvinc.com | |||
| Country | United States | |||
| Year Founded | 1993 | |||
| Profitability | PBSV - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -13.54% | |||
| Profit Margin | -8.17% | |||
| Management Effectiveness | PBSV - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -4.45% | |||
| Return on Equity | -- | |||
| Income Statement | PBSV - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 9.51M | |||
| Total Revenue (TTM) | 9.51M | |||
| Revenue Per Share | $0.41 | |||
| Gross Profit (TTM) | 2.52M | |||
| EBITDA (TTM) | -1.26M | |||
| EBIT (TTM) | -1.29M | |||
| Net Income (TTM) | -777.60K | |||
| Net Income Avl. to Common (TTM) | -777.60K | |||
| Total Revenue Growth (Q YOY) | -35.15% | |||
| Earnings Growth (Q YOY) | 134.18% | |||
| EPS Diluted (TTM) | -0.03 | |||
| EPS Diluted Growth (Q YOY) | 133.33% | |||
| Balance Sheet | PBSV - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 12.75M | |||
| Cash Per Share (Q) | $0.55 | |||
| Total Current Assets (Q) | 15.70M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 13.72M | |||
| Current Ratio (Q) | 8.319 | |||
| Book Value Per Share (Q) | $0.60 | |||
| Total Assets (Q) | 16.29M | |||
| Total Current Liabilities (Q) | 1.89M | |||
| Total Debt (Q) | 194.00K | |||
| Total Liabilities (Q) | 2.58M | |||
| Total Common Equity (Q) | 13.72M | |||
| Cash Flow | PBSV - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -1.36M | |||
| Cash from Financing (TTM) | -1.73M | |||
| Net Change in Cash (TTM) | -3.68M | |||
| Levered Free Cash Flow (TTM) | 455.60K | |||
| Cash from Operations (TTM) | -566.70K | |||
